sepsis Clinical Trials and Research
Also known as: blood poisoning, septic shock, systemic inflammatory response syndrome (sirs), severe sepsis, septicemia · ICD-10: A41.9
Sepsis is a life-threatening condition caused by the body's overwhelming response to an infection, leading to organ damage. Clinical trial research for sepsis focuses on improving early diagnosis, developing new treatments, and understanding disease mechanisms. Find a Trial helps patients search for active studies investigating sepsis.
Common questions about sepsis clinical trials
What is sepsis and why are clinical trials important for it?
Sepsis is a severe medical emergency where the body's immune system overreacts to an infection, potentially causing organ failure and death. Clinical trials are vital for sepsis because they test new ways to diagnose, treat, and prevent this complex condition, aiming to improve patient outcomes based on data from ClinicalTrials.gov and NIH RePORTER.
What types of treatments are being studied for sepsis in clinical trials?
Sepsis clinical trials investigate a range of interventions, including novel antibiotics, anti-inflammatory drugs, immune modulators, and supportive care strategies like fluid management and vasopressors. Researchers also explore personalized medicine approaches to tailor treatments, according to information from ClinicalTrials.gov and NIH RePORTER.
Who can participate in sepsis clinical trials?
Eligibility for sepsis clinical trials varies widely depending on the study's specific goals. Generally, participants must meet criteria related to their age, the severity and stage of their sepsis, and their overall health status. Each study has unique inclusion and exclusion criteria, as detailed on ClinicalTrials.gov.
What are common exclusion criteria for sepsis clinical trials?
Common exclusion criteria in sepsis trials often include pre-existing severe organ dysfunction, certain co-morbidities like advanced cancer or immunosuppression, pregnancy, or recent participation in another clinical trial. These criteria help ensure patient safety and the study's scientific integrity, based on data from ClinicalTrials.gov.
What are the different phases of sepsis clinical trials?
Sepsis clinical trials progress through phases. Phase 1 studies test safety in a small group, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to existing ones in larger populations. Phase 4 studies monitor long-term safety and efficacy after approval, as outlined on ClinicalTrials.gov.
Do patients have to pay to participate in sepsis clinical trials?
Typically, participants do not pay for the investigational treatments or procedures directly related to a clinical trial for sepsis. Study sponsors often cover these costs. However, standard medical care expenses not directly part of the trial may still be billed to insurance, according to information from ClinicalTrials.gov.
What biomarkers are often studied in sepsis clinical trials?
Sepsis clinical trials frequently investigate biomarkers such as procalcitonin, C-reactive protein, lactate, and various cytokines to aid in early diagnosis, predict severity, and monitor treatment response. Researchers are also exploring new genetic and proteomic markers to improve patient stratification, based on data from NIH RePORTER.
Where can I find active clinical trials for sepsis?
You can find active clinical trials for sepsis by searching online databases like ClinicalTrials.gov, which is maintained by the U.S. National Library of Medicine. Find a Trial also provides a user-friendly platform to search for studies based on your condition and location, helping you connect with research opportunities.
How to find a sepsis trial that fits you
- Describe your sepsis situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.